Improved assessment of Plasmodium vivax response to antimalarial drugs by a colorimetric double-site Plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 6, 2007, Pages 2112-2116

  Druilhe, Pierre ^a   Brasseur, Philippe ^b   Blanc, Catherine ^a   Makler, Michael ^c  

^a INSTITUT PASTEUR   (France)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^c Flow Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; LACTATE DEHYDROGENASE; PYRONARIDINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; COLORIMETRY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; NONHUMAN; PARASITE EXAMINATION; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, PROTOZOAN; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; COLORIMETRY; DRUG RESISTANCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; L-LACTATE DEHYDROGENASE; MYANMAR; PARASITIC SENSITIVITY TESTS; PLASMODIUM VIVAX; SENSITIVITY AND SPECIFICITY;

EID: 34250219978     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01385-06     Document Type: Article

References (30)

1. Baird, J. K., H. Basri, Purnomo, M. J. Bang, B. Subianto, I. Patchen, and S. L. Hoffman. 1991. Resistance to chloroquine by Plasmodium vivax in Irian Jaya. Am. J. Trop. Med. Hyg. 44:547-552.
2. Baird, J. K., H. Basri, B. Subianto, D. J. Fryauff, P. D. McElroy, B. Leksana, T. L. Richie, S. Masbar, F. S. Wignall, and S. L. Hoffman. 1995. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. J. Infect. Dis. 171:1678-1682.
3. Baird, J. K., B. Leksana, S. Masbar, D. J. Fryauff, M. A. Sutanihardja, Suradi, F. S. Wignall, and S. I. Hoffman. 1997. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine concentrations. Am. J. Trop. Med. Hyg. 56:621-626.
4. Baird, J. K. 2004. Chloroquine resistance in Plasmodium vivax. Antimicrob. Agents Chemother. 48:4075-4083.
5. Basco, L. K., and J. Le Bras. 1994. Short term in vitro culture of Plasmodium vivax and P. ovale for drug-susceptibility testing. Parasitol. Res. 80:262-264.
6. Brockelman, C. R., A. P. Tan-Ariya, and D. Bunnag. 1989. Development of in vitro microtest for the assessment of Plasmodium vivax sensitivity to chloroquine. South East Asian J. Trop. Med. Public Health 20:41-47.
7. Chotivanich, K., R. Udomsangpetch, W. Chierakul, P. N. Newton, R. Ruangveerayuth, S. Pukrittayakamee, S. Looareesuwan, and N. J. White. 2004. In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand. Am. J. Trop. Med. Hyg. 70:395-397.
8. Collignon, P. 1991. Chloroquine resistance in Plasmodium vivax. J. Infect. Dis. 164:222-223.
9. Congpuong, K., K. Na-Bangchang, K. Thimasarn, U. Tasanor, and W. H. Wernsdorfer. 2002. Sensitivity of Plasmodium vivax to chloroquine in Sa Kaeo Province, Thailand. Acta Trop. 83:117-121.
10. Druilhe, P., A. Moreno, C. Blanc, P. Brasseur, and P. Jacquier. 2001. Colorimetric in vitro drug sensitivity assay for P. falciparum based on a highly sensitive double-site pLDH antigen capture ELISA assay. Am. J. Trop. Med. Hyg. 64:233-241.
11. Garavelli, P. L., and E. Corti. 1992. Chloroquine resistance in Plasmodium vivax: the first case in Brazil. Trans. R. Soc. Trop. Med. Hyg. 86:128.
12. Garg, M., N. Gopinathan, P. Bodhe, and N. A. Kshirsagar. 1995. Vivax malaria resistant to chloroquine: cases reports from Bombay. Trans. R. Soc. Trop. Med. Hyg. 89:656-657.
13. Kosaisavee, V., R. Suwanarusk, F. Nosten, D. E. Kyle, M. Barrends, J. Jones, R. Price, B. Russel, and U. Lek-Uthai. 2006. Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isoplates. Exp. Parasitol. 114:34-39.
14. Looareesuwan, S., P. Wilairatana, S. Krudsood, S. Treeprasertsuk, P. Singhasivanon, V. Bussaratid, W. Chokjindachai, P. Viriyavejakul, K. Chalermrut, D. S. Walsh, and J. White. 1999. Chloroquine sensitivity of Plasmodium vivax in Thailand. Ann. Trop. Med. Parasitol. 93:225-230.
15. Marlar-Than, Myat-Phone-Kyaw, Aye-Yu-Soe, Khaing-Khaing-Gyi, Ma-Sabai, and Myint-Oo. 1995. Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Trans. R. Soc. Trop. Med. Hyg. 89:307-308.
16. Mendis, K., B. J. Sima, B. Marchesinin, and R. Carter. 2001. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64:97-106.
17. Myat-Phone-Kyaw, Mynt-Oo, Mynt-Lwin, Thaw-zin, Kian-Hla-Aye, and New-New-Yin. 1993. Emergence of chloroquine-resitant Plasmodium vivax in Myanmar (Burma). Trans. R. Soc. Trop. Med. Hyg. 87:687.
18. Phillips, E. J., J. S. Keystone, and K. C. Kain. 1996. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clin. Infect. Dis. 23:1171-1173.
19. Piper, R., J. Le Bras, L. Wentworth, A. Hunt-Cooke, S. Houze, P. Chiodini, and M. Makler. 1999. Immunocapture diagnostic assays for malaria using Plasmodium lactate dehydrogenase (pLDH). Am. J. Trop. Med. Hyg. 60:109-118.
20. Pradines, B., A. Tall, D. Parzy, A. Spiegel, T. Fusai, P. Hienne, J. F. Trape, and J. C. Doury. 1998. In vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents. J. Antimicrob. Chemother. 42:333-339.
21. Ridley, R. G. 2002. Chemotherapeutic hope on the horizon for Plasmodium vivax malaria? Proc. Natl. Acad. Sci. USA 99:13362- 13364.
22. Rieckmann, K. H., D. R. Davis, and D. C. Hutton. 1989. Plasmodium vivax resistance to chloroquine? Lancet ii:1183-1184.
23. Ruebush, T. K., J. Zegarra II, J. Cairo, E. M. Andersen, M. Green, D. R. Pillai, W. Marquino, M. Huilca, E. Arevalo, C. Garcia, L. Solary, and K. C. Kain. 2003. Chloroquine-resistant Plasmodium vivax malaria in Peru. Am. J. Trop. Med. Hyg. 69:548-552.
24. Russell, B. M., R. Udomsangpetch, K. H. Rieckmann, B. M. Kotecka, R. E. Coleman, and J. Satabongkot. 2003. Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic. Antimicrob. Agents Chemother. 47:170-173.
25. Schuurkamp, G., P. E. Spicer, R. K. Kereu, P. K. Bulungol, and K. H. Rieckmann. 1992. Chloroquine resistant P. vivax in Papua New Guinea. Trans. R. Soc. Trop. Med. Hyg. 86:121-122.
26. Schwartz, I. K., E. M. Lackritz, and L. C. Patchen. 1991. Chloroquine resistant Plasmodium vivax from Indonesia. N. Engl. J. Med. 1991:927.
27. Tasanor, O., H. Noedl, K. Na-Bangchang, K. Congpuong, J. Sirichaisinthop, and W. H. Wernsdorfer. 2002. An in vitro system for assessing the sensitivity of Plasmodium vivax chloroquine. Acta Trop. 83:49-61.
28. Van Den Abbeele, K., E. Van Den Enden, and J. Van Den Ende. 1995. Combined chloroquine and primaquine resistant Plasmodium vivax malaria in a patient returning from India. Ann. Soc. Belge Med. Trop. 75:73-74.
29. Vinetz, J. M. 2006. Emerging chloroquine-resistant Plasmodium vivax (benign tertian) malaria: the need for alternative drug treatment. Clin. Infect. Dis. 42:1073-1074.
30. Whitby, M., G. Wood, J. R. Veenendaal, and K. Rieckmann. 1989. Chloroquine-resistant Plasmodium vivax. Lancet ii:1395.